Successful CSO Long COVID Grant
Professor Colin Berry and team have been awarded £286,660 from the CSO to study the effects of long COVID.
The CISCO-21 Project Grant is therapy-focused and will examine the prevention and early treatment of COVID-19 long term effects via a randomised clinical trial of resistance exercise.
Many people have long-lasting symptoms after COVID-19, such as breathlessness, fatigue and chest pain. So far, research studies of treatments for COVID-19 have focused on the life-threatening acute illness; few studies look at treatments to improve long-term health after COVID-19. COVID-19, particularly when this requires a hospital admission, can lead to weight loss and muscle wasting, contributing to worse outcomes. Muscle strengthening (resistance-based) exercise could improve outcomes in the long-term.
We are looking to do two things:
- To undertake a research trial of pragmatic resistance-based exercise for 220 people recovering from COVID-19.
- Create a platform for rapid trials of new treatments after COVID-19. This will cut the costs of doing future trials and allow more patients the opportunity to contribute to medical research that will improve outcomes for people recovering from COVID19
For more information please contact Dr Stuart Gray - Stuart.Gray@Glasgow.ac.uk
First published: 17 August 2021